Potential of Blood Eosinophils, Eosinophil-Derived Neurotoxin, and Eotaxin-3 as Biomarkers of Eosinophilic Esophagitis

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 11, 2006, Pages 1328-1336

  Konikoff, Michael R ^a   Blanchard, Carine ^a   Kirby, Cassie ^a   Buckmeier, Bridget K ^a   Cohen, Mitchell B ^a   Heubi, James E ^a   Putnam, Philip E ^a   Rothenberg, Marc E ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EOSINOPHIL PROTEIN X; EOTAXIN; EOTAXIN 2; EOTAXIN 3; INTERLEUKIN 5; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; BLOOD LEVEL; CELL DENSITY; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOSCOPY; EOSINOPHIL; EOSINOPHIL COUNT; ESOPHAGITIS; FEMALE; HUMAN; MALE; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; BIOLOGICAL MARKERS; CHEMOKINES, CC; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILIA; EOSINOPHILS; ESOPHAGITIS; FEMALE; HUMANS; IMMUNOLOGIC FACTORS; INFANT; LEUKOCYTE COUNT; MALE; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 33750799063     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.08.013     Document Type: Article

References (32)

1. Rothenberg M.E. Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol 113 (2004) 11-29
2. Markowitz J.E., and Liacouras C.A. Eosinophilic esophagitis. Gastroenterol Clin North Am 32 (2003) 949-966
3. Liacouras C.A. Eosinophilic esophagitis in children and adults. J Pediatr Gastroenterol Nutr 37 (2003) S23-S28
4. Kelly K.J., Lazenby A.J., Rowe P.C., et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 109 (1995) 1503-1512
5. Markowitz J.E., Spergel J.M., Ruchelli E., et al. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 98 (2003) 777-782
6. Mishra A., Hogan S.P., Brandt E.B., et al. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 107 (2001) 83-90
7. Fox V.L., Nurko S., and Furuta G.T. Eosinophilic esophagitis: it's not just kid's stuff. Gastrointest Endosc 56 (2002) 260-270
8. Straumann A., Spichtin H.P., Grize L., et al. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 125 (2003) 1660-1669
9. Spergel J.M., Andrews T., Brown-Whitehorn T.F., et al. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol 95 (2005) 336-343
10. Liacouras C.A., Wenner W.J., Brown K., et al. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr 26 (1998) 380-385
11. Faubion Jr. W.A., Perrault J., Burgart L.J., et al. Treatment of eosinophilic esophagitis with inhaled corticosteroids. J Pediatr Gastroenterol Nutr 27 (1998) 90-93
12. Noel R.J., Putnam P.E., Collins M.H., et al. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2 (2004) 568-575
13. Teitelbaum J.E., Fox V.L., Twarog F.J., et al. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 122 (2002) 1216-1225
14. Rothenberg M.E. Eosinophilia. N Engl J Med 338 (1998) 1592-1600
15. Bischoff S.C., Grabowsky J., and Manns M.P. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls. Dig Dis Sci 42 (1997) 394-403
16. Koller D.Y., Halmerbauer G., Frischer T., et al. Assessment of eosinophil granule proteins in various body fluids: is there a relation to clinical variables in childhood asthma?. Clin Exp Allergy 29 (1999) 786-793
17. Peterson C.G., Eklund E., Taha Y., et al. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease. Am J Gastroenterol 97 (2002) 1755-1762
18. Mishra A., Hogan S.P., Brandt E.B., et al. IL-5 promotes eosinophil trafficking to the esophagus. J Immunol 168 (2002) 2464-2469
19. Mishra A., and Rothenberg M.E. Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology 125 (2003) 1419-1427
20. Joseph J., Benedict S., Safa W., et al. Serum interleukin-5 levels are elevated in mild and moderate persistent asthma irrespective of regular inhaled glucocorticoid therapy. BMC Pulm Med 4 (2004) 2
21. Straumann A., Bauer M., Fischer B., et al. Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 108 (2001) 954-961
22. Blanchard C., Wang N., Stringer K.F., et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest 116 (2006) 536-547
23. Jahnz-Royk K., Plusa T., and Mierzejewska J. Eotaxin in serum of patients with asthma or chronic obstructive pulmonary disease: relationship with eosinophil cationic protein and lung function. Mediators Inflamm 9 (2000) 175-179
24. Mir A., Minguez M., Tatay J., et al. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am J Gastroenterol 97 (2002) 1452-1457
25. Ruchelli E., Wenner W., Voytek T., et al. Severity of esophageal eosinophilia predicts response to conventional gastroesophageal reflux therapy. Pediatr Dev Pathol 2 (1999) 15-18
26. Esposito S., Marinello D., Paracchini R., et al. Long-term follow-up of symptoms and peripheral eosinophil counts in seven children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 38 (2004) 452-456
27. Munitiz V., Martinez de Haro L.F., Ortiz A., et al. Primary eosinophilic esophagitis. Dis Esophagus 16 (2003) 165-168
28. Orenstein S.R., Shalaby T.M., Di Lorenzo C., et al. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children. Am J Gastroenterol 95 (2000) 1422-1430
29. Remedios M., Campbell C., Jones D.M., et al. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc 63 (2006) 3-12
30. DeBrosse C.W., Case J.W., Putnam P.E., et al. Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatr Dev Pathol 9 (2006) 210-218
31. Garrett J.K., Jameson S.C., Thomson B., et al. Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113 (2004) 115-119
32. Stein ML, Collins MH, Villanueva JM, et al. Anti-interleukin-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol (in press).